Interestingly, a variant of SUMO4 (M55V) strongly associated with T1DM results in 5.5 times greater NF-κB transcriptional activity by conjugating to NF-κB inhibitor IκBα18, 19. This evidence concerns the gene SUMO4 and type 1 diabetes mellitus.